Estradiol-induced hyperplasia in endometrial biopsies from women on hormone replacement therapy

American Journal of Surgical Pathology

Volumn 26, Issue 10, 2002, Pages 1269-1275

  Wright, Thomas C ^a   Holinka, Christian F ^e   Ferenczy, Alex ^f   Gatsonis, Constantine A ^d   Mutter, George L ^b   Nicosia, Santo ^c   Richart, Ralph M ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d BROWN UNIVERSITY   (United States)

^e PharmConsult   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL;

ARTICLE; DISEASE CLASSIFICATION; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OBSERVER VARIATION; PATHOLOGIST; REPRODUCIBILITY;

BIOPSY; ENDOMETRIAL HYPERPLASIA; ENDOMETRIUM; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 0036789057     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200210000-00003     Document Type: Article

References (26)

1. American Cancer Society. Cancer Facts & Figures: 2000. Atlanta: American Cancer Society, 2000.
2. Andrion A, Magnani C, Betta PG, et al. Malignant mesothelioma of the pleura: interobserver variability. J Clin Pathol 1995;48: 856-60.
3. Archer DF, McIntyre-Seltman K, Wilborn WW Jr, et al. Endometrial morphology in asymptomatic postmenopausal women. Am J Obstet Gynecol 1991;165:317-22.
4. Bergeron C, Nogales FF, Masseroli M, et al. A multicentric European study testing the reproducibility of the WHO classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens. Am J Surg Pathol 1999;23:1102-8.
5. Cramer SF. Interobserver variability in surgical pathology. Adv Pathol 1996;9:3-82.
6. Cramer SF. Interobserver variability in dermatopathology. Arch Dermatol 1997;133:1033-6.
7. Epstein JI, Grignon DJ, Humphrey PA, et al. Interobserver reproducibility in the diagnosis of prostatic intraepithelial neoplasia. Am J Surg Pathol 1995;19:873-86.
8. European Agency for the Evaluation of Medicinal Products (Human Medicines Evaluation Unit, Committee for Proprietary Medicinal Products). Points to Consider on Hormone Replacement Therapy. London: European Agency for the Evaluation of Medicinal Products, 1997.
9. Ferrara G, Argenziano G, Soyer HP, et al. Histopathologic interobserver agreement on the diagnosis of melanocytic skin lesions with equivocal dermoscopic features: a pilot study. Tumori 2000;86: 445-9.
10. Giardina C, Clemente R, Fusilli S, et al. Interobserver reproducibility in diagnosis of breast lesions: a panel in Puglia (Italy). Tumori 1998;84:354-9.
11. Grady D, Gebretsadik T, Kerlikowske K, et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995;85:304-13.
12. Gusberg SB. Precursors of corpus carcinoma: estrogens and adenomatous hyperplasia. Am J Obstet Gynecol 1947;54:905-27.
13. Hulley S, Grady D, Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 1998;280:605-13.
14. Korhonen MO, Symons JP, Hyde BM, et al. Histologic classification and pathologic findings for endometrial biopsy specimens obtained from 2964 perimenopausal and postmenopausal women undergoing screening for continuous hormones as replacement therapy (CHART 2 Study). Am J Obstet Gynecol 1997;176: 377-80.
15. Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia: a long-term study of 'untreated' hyperplasia in 170 cases. Cancer 1985;56:403-12.
16. Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract, 4th ed. New York: Springer-Verlag, 1994:411-27.
17. Kurman RJ, Felix JC, Archer DF, et al. Norethisterone acetate and estradiol-induced endometrial hyperplasia. Obstet Gynecol 2000; 96:373-9.
18. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
19. Mutter GL. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol 2000;19:301-9.
20. Mutter GL, Baak JPA, Crum CP, et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 2000;190:462-9.
21. Raab SS, Robinson RA, Jensen CS, et al. Mucinous tumors of the ovary: interobserver diagnostic variability and utility of sectioning protocols. Arch Pathol Lab Med 1997;121:1192-8.
22. Sakamoto A, Sasaki H, Furusato M, et al. Observer disagreement in histologic classification of ovarian tumors in Japan. Gynecol Oncol 1994;54:54-8.
23. Speroff L, Rowan J, Symons J, et al. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study). JAMA 1996;276:1397-403.
24. U.S. Department of Health and Human Services, Food and Drug Administration (Center for Drug Evaluation and Research). Guidance for Clinical Evaluation of Combination Estrogen/Progestin-Containing Drug Products Used for Hormone Replacement Therapy of Postmenopausal Women. Rockville, MD: Food and Drug Administration, 1995.
25. Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1996;275:370-5.
26. Zaino RJ. Endometrial hyperplasia: Is it time for a quantum leap to a new classification? Int J Gynecol Pathol 2000;19:314-21.